|  | All patients | ||||
---|---|---|---|---|---|---|
 |  | All (n = 377) | No (n = 321) | Yes (n = 56) | p-value | pBH-value |
Bra cup size | Â | Â | Â | Â | Â | Â |
 | A + B + C | 269 (71.4) | 242 (90.0) | 27 (10.0) |  |  |
 | ≥D | 103 (27.3) | 76 (73.8) | 27 (26.2) | <0.001 | 0.001 |
BMI | Â | Â | Â | Â | Â | Â |
 | Median | 26 | 25 | 29 |  |  |
 | Range | 16-50 | 16-40 | 21-50 | <0.001 | <0.001 |
Fractionation | Â | Â | Â | Â | Â | Â |
 | Normo | 45 (11.9) | 22 (48.9) | 23 (51.1) |  |  |
 | Hypo | 332 (88.1) | 299 (90.1) | 33 (9.9) | <0.001 | <0.001 |
Treatment position | Â | Â | Â | Â | Â | Â |
 | Supine | 290 (76.9) | 239 (82.4) | 51 (17.6) |  |  |
 | Prone | 87 (23.1) | 82 (94.3) | 5 (5.7) | 0.002 | 0.019 |
Hormonal therapy | Â | Â | Â | Â | Â | Â |
 | No | 71 (18.8) | 62 (87.3) | 9 (12.7) |  |  |
 | Concomitant | 243 (64.5) | 214 (88.1) | 29 (11.9) |  |  |
 | Sequential (after IMRT) | 63 (16.7) | 45 (71.4) | 18 (28.6) | 0.004 | 0.029 |
 | Hormones (concomitant) |  |  |  |  |  |
 | Tamoxifen | 155 | 139 (89.7) | 16 (10.3) |  |  |
 | Aromatase inhibitor | 85 | 74 (87.1) | 11 (12.9) |  |  |